Real-time reviews for cell and gene therapies? Pfizer to FDA: Yes, please

The FDA’s Oncology Center of Excellence has a program, known as Real-Time Oncology Review (RTOR), that speeds up cancer drug approvals, sometimes by months, but has always been restricted to cancer drugs — first with supplements and then moving on to full approvals.